Results 231 to 240 of about 4,194,617 (361)
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Proposed Legislation on Short Term Time Off in the 108th Congress [PDF]
Workplace Flexibility 2010, Georgetown University Law Center
core +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Summary Comparison of Select Foreign EXTO Laws [PDF]
Workplace Flexibility 2010, Georgetown University Law Center
core +1 more source
A call for congressional action: revisiting the U.S. coordinated framework for the regulation of biotechnology. [PDF]
Buchman L, Kovak E.
europepmc +1 more source
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto +13 more
wiley +1 more source
Eligibility for Medical & Family Leave Under the FMLA: Development of the Statutory Text 1985-1993 [PDF]
Workplace Flexibility 2010, Georgetown University Law Center
core +1 more source
Microbiological quality of drinking water from water dispensers. [PDF]
Hile TD, Leal R, Dunbar SG, Sinclair RG.
europepmc +1 more source

